Overview:

There are signs that China’s economy is gradually recovering from financial crisis, with good economic performance having been achieved in recent two months.

As for corn processing industry, most enterprises’ operating rates have kept increasing. Attributed to the relatively small corn supply, domestic corn price has maintained the uptrend and exceeded USD240/t in August, though Chinese government is selling its purchased 40 million tonnes of corn in Northeast China.

Prices of some corn products like malt syrup, threonine and VB2 have also maintained upswing in August.

Some enterprises have shown good performance. For instance, Northeast Pharmaceutical has witnessed 120% net profit increase in H1 2009. And COFCO has been engaged in starch sugar production by taking over Shanghai Rongshi Biotechnology. Shandong Baolingbao got listed on 19th Aug. to raise fund for further expansion. Some other enterprises also plan to expand production, such as Tianjin Novozymes, Guangxi Danbaoli and Continent Biotech and so on.

Besides, Tongliao CNE, who has ever stopped butanol production since the outbreak of financial crisis, is expanding butanol capacity with firm belief in the bright future of butanol.

China has successfully localized L-Tryptophan production.
Shandong’s malt syrup price has been increasing with the rising prices of corn and sucrose.
Domestic threonine price may continue downtrend in the following months.
Domestic VB2 price has maintained uptrend in late July.
Xylitol price has declined this August owing to increasing operating rate.
COFCO successfully purchased Rongshi Biotechnology at the end of July.
Novozymes is to double its enzyme production capacity in Tianjin.
Baolingbao successfully got listed on Shenzhen Stock Exchange on Aug. 19th 2009.
Shandong is going to build fuel ethanol plants to meet its own demand.
Northeast Pharmaceutical achieved net profit of USD45.8 million in H1 2009, up 120% over the same period of last year.
Guangxi Danbaoli and Guangxi Yipinxian will launch their yeast production lines this October.
Tongliao CNE is expanding its corn-based solvent capacity to 100,000t/a.
Continent Biotech is building a 15,000t/a enzyme preparation plant in Weifang.
China’s corn yield is expected to rise in 2009.
Chinese government has begun to gradually release its large corn storage since July 2009.
COFCO has begun marketing its new corn oil product with phytosterol content of 13,000ppm under the brand Fortune since July.


Companies Mentioned

Agri-Industries Holdings Ltd.
Baolingbao Biology Co., Ltd.
Shandong Fulaichun Group Co., Ltd.
Qingzhou Yunmen Wine Group Co., Ltd.
Northeast Pharmaceutical Group Co., Ltd.
Guangxi Danbaoli yeast Co., Ltd.
Tongliao CNE Starch Co., Ltd.

Domestic L-Tryptophan production accelerating

Ex-factory prices of corn products in Aug. 2009
FOB corn price change in Dalian Port from Sep. 2008 to Aug. 2009
Malt syrup price rising in Shandong
Domestic threonine price to maintain downtrend
VB2 price maintains uptrend in late July
Xylitol price declines slightly in August

COFCO purchases Rongshi Biotechnology
Novozymes to expand enzyme preparation capacity in China
Baolingbao gets listed
Shandong to build fuel ethanol plants
Northeast Pharmaceutical net profit up 120% in H1 2009
Guangxi Danbaoli to launch yeast facilities
Tongliao CNE expanding corn-based solvent capacity
Continent Biotech builds 15,000t/a enzyme preparation plant

China’s corn yield expected to rise in 2009
China to largely release corn storage

COFCO marketing corn oil with 13,000ppm phytosterol

EU’s anti-dumping investigation on China’s sodium gluconate
BBCA sees 76.84% increase in net profit in H1 2009
Gansu Shengdafangzhou to launch modified starch plant
Ningxia Eppen launches threonine production line
COFCO expansion in Guangxi